Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Otsuka Pharmaceuticals main competitors are Novartis, Novo Nordisk, and Allergan plc.
Competitor Summary. See how Otsuka Pharmaceuticals compares to its main competitors:
| Company | Founding date | Zippia score | Headquarters | # of Locations | Revenue | Employees |
|---|---|---|---|---|---|---|
| 1989 | 4.9 | Rockville, MD | 3 | $4.4B | 7,500 | |
| 1954 | 4.8 | New York, NY | 1 | $3.6B | 6,200 | |
| 2012 | 4.5 | - | - | $53.0M | 635 | |
| 1998 | 4.6 | San Diego, CA | 1 | $144.0M | 281 | |
| 1987 | 4.7 | South San Francisco, CA | 1 | $61.0B | 94,442 | |
| 1923 | 4.9 | Princeton, NJ | 4 | $16.2B | 42,682 | |
| 2001 | 4.9 | Northbrook, IL | 7 | $11.1B | 17,217 | |
| 1996 | 4.9 | East Hanover, NJ | 16 | $51.7B | 110,000 | |
| 1896 | 4.1 | - | - | $200,000 | 500 | |
| 1948 | 4.8 | Irvine, CA | 1 | $7.2B | 11,400 | |
| 2004 | 4.9 | Wayne, PA | 1 | $15.2B | 3,500 | |
| 1950 | 4.5 | Hawthorne, NY | 1 | $862.9M | 1,339 | |
| 1974 | 4.2 | Mahwah, NJ | 2 | $110.0M | 620 | |
| 1987 | 4.6 | Houston, TX | 3 | $291.6M | 660 |
Rate how well Otsuka Pharmaceuticals differentiates itself from its competitors.
| Company | Highest salary | Hourly salary |
|---|---|---|
Otsuka Pharmaceuticals | $74,699 | $35.91 |
Novo Nordisk | $126,789 | $60.96 |
Allergan plc | $121,561 | $58.44 |
Novartis | $120,883 | $58.12 |
Forest Laboratories | $119,720 | $57.56 |
Cyberonics | $85,138 | $40.93 |
Roche Diagnostics Middle East | $82,403 | $39.62 |
Roche Holding AG | $79,994 | $38.46 |
Astellas Pharma | $75,713 | $36.40 |
Shire Pharmaceuticals Inc | $74,317 | $35.73 |
Biopharma | $73,950 | $35.55 |
Taro Pharmaceutical Industries | $72,247 | $34.73 |
Optimer Pharmaceuticals | $68,161 | $32.77 |
HealthSTAR Communications | $64,968 | $31.23 |
Do you work at Otsuka Pharmaceuticals?
Does Otsuka Pharmaceuticals effectively differentiate itself from competitors?
| Job title | Male | Female |
|---|---|---|
| Novo Nordisk | 49% | 51% |
| Novartis | 54% | 46% |
| Allergan plc | 55% | 45% |
| Roche Holding AG | 56% | 44% |
| Astellas Pharma | 58% | 42% |
| Otsuka Pharmaceuticals | - | - |
| Company | White | Hispanic or Latino | Black or African American | Asian | Unknown | Diversity score |
|---|---|---|---|---|---|---|
| 51% | 12% | 11% | 21% | 5% | 9.8 | |
| 55% | 15% | 10% | 15% | 4% | 9.9 | |
| 58% | 13% | 12% | 12% | 4% | 10.0 | |
| 57% | 17% | 10% | 12% | 4% | 9.8 | |
| 52% | 19% | 10% | 15% | 5% | 9.9 | |
| 55% | 13% | 11% | 15% | 6% | 9.0 |